Farallon Capital Management’s Evolent Health EVH Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $158K | Hold |
14,000
| – | – | ﹤0.01% | 120 |
|
|
2025
Q1 | $133K | Hold |
14,000
| – | – | ﹤0.01% | 124 |
|
|
2024
Q4 | $158K | Sell |
14,000
-625,000
| -98% | -$7.03M | ﹤0.01% | 126 |
|
|
2024
Q3 | $18.1M | Buy |
+639,000
| New | +$18.1M | 0.08% | 71 |
|
|
2024
Q2 | – | Sell |
-1,037,331
| Closed | -$34M | – | 169 |
|
|
2024
Q1 | $34M | Sell |
1,037,331
-1,126,578
| -52% | -$36.9M | 0.14% | 58 |
|
|
2023
Q4 | $71.5M | Buy |
2,163,909
+263,000
| +14% | +$8.69M | 0.33% | 52 |
|
|
2023
Q3 | $51.8M | Hold |
1,900,909
| – | – | 0.24% | 56 |
|
|
2023
Q2 | $57.6M | Buy |
1,900,909
+757,000
| +66% | +$22.9M | 0.29% | 64 |
|
|
2023
Q1 | $37.1M | Buy |
1,143,909
+841,909
| +279% | +$27.3M | 0.2% | 66 |
|
|
2022
Q4 | $8.48M | Buy |
+302,000
| New | +$8.48M | 0.05% | 113 |
|